BioPortfolio - Cytovax Biotechnologies Incorporated
Cytovax Biotechnologies Incorporated - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/3191-Cytovax_Biotec...
|
Use of monoclonal fluorescent antibodies for the detection of B ...
Cytovax Biotechnologies Inc., Edmonton, Alberta, Canada. astadel@cytovax.com. While it has been said that PCR is likely to replace DFA as the test of choice
...
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&d...
|
BioPortfolio - Cytovax Biotechnologies Incorporated - Profile
View the current Cytovax Biotechnologies Incorporated Page on BioPortfolio.com ... Cytovax Biotechnologies Inc. is a biotechnology company focused on the ...
http://www.bioportfolio.com/biocorporate/3191-Cytovax+Biotec...
|
BioSpace - Cytovax Biotechnologies Inc. News, Search Jobs, Events
Company Profile. Cytovax Biotechnologies Inc. 8223 Roper Road Edmonton Alberta T6E 6S4 Canada Phone: 780-448-0621 Fax: 780-448-0624 ...
http://www.biospace.com/company_profile.aspx?CompanyId=49004...
|
BioPortfolio - Biocorporate Search Antibody
Cytovax Biotechnologies Inc. is a biotechnology company focused on the development of ... Cytovax is developing new,... www.cytovax.com/ View full
profile ...
http://www.bioportfolio.com/biocorporate/Antibody-companies....
|
1743-422X-2-56 1743-422X Research Re-evaluating the role of ...
... through immunoaffinity B cell and T cell columns according to the manufacturer's directions (Cytovax Biotechnologies Inc., Edmonton, Alberta,
Canada). ...
http://www.biomedcentral.com/content/download/xml/1743-422x-...
|
2002 Research & Development Briefing
probe study being conducted by Cytovax Biotechnologies. Oncology. Pancreatic cancer and acute myelogenous leukaemia. TROXATYL is a dioxolane nucleoside ...
http://www.shire.com/shire/uploads/press/shire/R_D_Day_press...
|
{1} Release: Sixty Pacific Northwest Life Science Companies Tapped ...
Seattle, WA Corus Pharma Inc. Seattle, WA Cytopeia, Inc. Seattle, WA CytoVax Biotechnologies Inc. Edmonton, AB Dendreon Corp. Seattle, WA Epigenomics Inc.
...
http://www.biospace.com/news_story.aspx?NewsEntityId=1488772...
|
BioWorld Today - Nov 6, 2000
Cytovax Completes $5M Funding To Move Cytovaxine Into Clinic · Other News To Note · European Patent Disclosures. The above issue is also available as one ...
http://www.bioworld.com/servlet/com.accumedia.web.Dispatcher...
|
Exploring the feasibility of selective depletion of T lymphocyte ...
These methods are based on both negative selection (e.g. human CD4 enrichment column; R&D Systems [Minneapolis, MN, USA], Cellect, Cytovax Biotec [Edmonton,
...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=22...
|
